Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
Work
Year: 2013
Type: article
Source: Blood
Authors Daniel H. Fowler, Miriam E. Mossoba, Seth M. Steinberg, David Halverson, David F. Stroncek +20 more
Institutions National Cancer Institute, National Institutes of Health, Hackensack University Medical Center, University of Pennsylvania, Cancer Research Center
Cites: 51
Cited by: 31
Related to: 10
FWCI: 3.145
Citation percentile (by year/subfield): 81.34
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze